{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:57:04Z","timestamp":1790585824952,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82560036"],"award-info":[{"award-number":["82560036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20252BAC240524"],"award-info":[{"award-number":["20252BAC240524"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02379-3","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:58:48Z","timestamp":1790528328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning-driven M2 macrophage signature for precision prediction of survival and therapy response in acute myeloid leukemia"],"prefix":"10.1007","volume":"75","author":[{"given":"Fangmin","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingze","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"key":"2379_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.27625","volume":"100","author":"S Shimony","year":"2025","unstructured":"Shimony S, Stahl M, Stone RM, Acute Myeloid L. 2025 Update on diagnosis, risk-stratification, and management. Am J Hematol. 2025;100:860\u201391. https:\/\/doi.org\/10.1002\/ajh.27625.","journal-title":"Am J Hematol"},{"key":"2379_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3322\/caac.21873","volume":"75","author":"HM Kantarjian","year":"2025","unstructured":"Kantarjian HM, et al. Acute myeloid leukemia management and research in 2025. Cancer J Clin. 2025;75:46\u201367. https:\/\/doi.org\/10.3322\/caac.21873.","journal-title":"Cancer J Clin"},{"key":"2379_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3324\/haematol.2022.280801","volume":"108","author":"S Kayser","year":"2023","unstructured":"Kayser S, Levis MJ. The clinical impact of the molecular landscape of acute myeloid leukemia. Haematologica. 2023;108:308\u201320. https:\/\/doi.org\/10.3324\/haematol.2022.280801.","journal-title":"Haematologica"},{"key":"2379_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40164-021-00233-2","volume":"10","author":"Y Yao","year":"2021","unstructured":"Yao Y, Li F, Huang J, Jin J, Wang H. Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development. Experimental Hematol Oncol. 2021;10:39. https:\/\/doi.org\/10.1186\/s40164-021-00233-2.","journal-title":"Experimental Hematol Oncol"},{"key":"2379_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12964-023-01282-2","volume":"21","author":"M Bakhtiyari","year":"2023","unstructured":"Bakhtiyari M, et al. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways. Cell communication signaling: CCS. 2023;21:252. https:\/\/doi.org\/10.1186\/s12964-023-01282-2.","journal-title":"Cell communication signaling: CCS"},{"key":"2379_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41375-021-01350-x","volume":"36","author":"S Tettamanti","year":"2022","unstructured":"Tettamanti S, Pievani A, Biondi A, Dotti G, Serafini M. Catch me if you can: how AML and its niche escape immunotherapy. Leukemia. 2022;36:13\u201322. https:\/\/doi.org\/10.1038\/s41375-021-01350-x.","journal-title":"Leukemia"},{"key":"2379_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01452-1","author":"S Chen","year":"2023","unstructured":"Chen S, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Therapy. 2023. https:\/\/doi.org\/10.1038\/s41392-023-01452-1.","journal-title":"Signal Transduct Target therapy"},{"key":"2379_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888713","author":"J Gao","year":"2022","unstructured":"Gao J, Liang Y, Wang L Shaping polarization of tumor-associated macrophages in cancer immunotherapy. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.888713.","journal-title":"Front Immunol"},{"key":"2379_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s44313-025-00119-w","volume":"61","author":"ZG Chen","year":"2026","unstructured":"Chen ZG, et al. Macrophage polarization in hematologic cancers: mechanisms and therapeutic strategies. Blood Res. 2026;61:8. https:\/\/doi.org\/10.1007\/s44313-025-00119-w.","journal-title":"Blood Res"},{"key":"2379_CR10","doi-asserted-by":"publisher","first-page":"1683347","DOI":"10.1080\/2162402x.2019.1683347","volume":"9","author":"ZJ Xu","year":"2020","unstructured":"Xu ZJ, et al. The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia. Oncoimmunology. 2020;9:1683347. https:\/\/doi.org\/10.1080\/2162402x.2019.1683347.","journal-title":"Oncoimmunology"},{"key":"2379_CR11","doi-asserted-by":"publisher","first-page":"26123","DOI":"10.1038\/s41598-025-03557-9","volume":"15","author":"AA Navidinia","year":"2025","unstructured":"Navidinia AA, et al. Constructing a tumor immune microenvironment-driven prognostic model in acute myeloid leukemia using bioinformatics and validation data. Sci Rep. 2025;15:26123. https:\/\/doi.org\/10.1038\/s41598-025-03557-9.","journal-title":"Sci Rep"},{"key":"2379_CR12","doi-asserted-by":"publisher","first-page":"eadf8522","DOI":"10.1126\/sciadv.adf8522","volume":"9","author":"I Weinh\u00e4user","year":"2023","unstructured":"Weinh\u00e4user I, et al. M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism. Sci Adv. 2023;9:eadf8522. https:\/\/doi.org\/10.1126\/sciadv.adf8522.","journal-title":"Sci Adv"},{"key":"2379_CR13","doi-asserted-by":"publisher","first-page":"14012","DOI":"10.1038\/s41598-024-64567-7","volume":"14","author":"Y Zhan","year":"2024","unstructured":"Zhan Y, et al. Identification of a novel monocyte\/macrophage-related gene signature for predicting survival and immune response in acute myeloid leukemia. Sci Rep. 2024;14:14012. https:\/\/doi.org\/10.1038\/s41598-024-64567-7.","journal-title":"Sci Rep"},{"key":"2379_CR14","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1111\/cas.70044","volume":"116","author":"J Yin","year":"2025","unstructured":"Yin J, Luo J, Wang L, Liu L, Liu L. STAB1 Promotes acute myeloid leukemia progression by activating the IKK\/NF-\u03baB Pathway and increasing M2 macrophage polarization. Cancer Sci. 2025;116:1508\u201321. https:\/\/doi.org\/10.1111\/cas.70044.","journal-title":"Cancer Sci"},{"key":"2379_CR15","doi-asserted-by":"publisher","first-page":"5125","DOI":"10.1007\/s00277-025-06688-1","volume":"104","author":"S Tang","year":"2025","unstructured":"Tang S, et al. NIPA1 depletion in tumor-associated macrophages via IGFBP2\/EGFR attenuates acute myeloid leukemia progression and chemoresistance. Ann Hematol. 2025;104:5125\u201337. https:\/\/doi.org\/10.1007\/s00277-025-06688-1.","journal-title":"Ann Hematol"},{"key":"2379_CR16","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen P, et al. Single-Cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity. Cell. 2019;176:1265\u2013e12811224. https:\/\/doi.org\/10.1016\/j.cell.2019.01.031.","journal-title":"Cell"},{"key":"2379_CR17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"A Newman","year":"2015","unstructured":"Newman A, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"key":"2379_CR18","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox N, Huang R. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE. 2014;9:e107468. https:\/\/doi.org\/10.1371\/journal.pone.0107468.","journal-title":"PLoS ONE"},{"key":"2379_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1158\/1078-0432.Ccr-20-3417","volume":"27","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. An immune risk score predicts survival of patients with acute myeloid leukemia receiving chemotherapy. Clin Cancer Res. 2021;27:255\u201366. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-3417.","journal-title":"Clin Cancer Res"},{"key":"2379_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cells14100741","author":"AF Saeed","year":"2025","unstructured":"Saeed AF. Tumor-associated macrophages: polarization, immunoregulation, and immunotherapy. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14100741.","journal-title":"Cells"},{"key":"2379_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002319","author":"D Baumann","year":"2021","unstructured":"Baumann D, et al. p38 MAPK signaling in M1 macrophages results in selective elimination of M2 macrophages by MEK inhibition. J Immunother Cancer. 2021. https:\/\/doi.org\/10.1136\/jitc-2020-002319.","journal-title":"J Immunother Cancer"},{"key":"2379_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.gendis.2021.10.010","volume":"10","author":"P Zhang","year":"2023","unstructured":"Zhang P, et al. The role of autophagy in regulating metabolism in the tumor microenvironment. Genes Dis. 2023;10:447\u201356. https:\/\/doi.org\/10.1016\/j.gendis.2021.10.010.","journal-title":"Genes Dis"},{"key":"2379_CR23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.cmet.2022.12.005","volume":"35","author":"YT Wang","year":"2023","unstructured":"Wang YT, et al. Metabolic adaptation supports enhanced macrophage efferocytosis in limited-oxygen environments. Cell Metab. 2023;35:316\u2013e331316. https:\/\/doi.org\/10.1016\/j.cmet.2022.12.005.","journal-title":"Cell Metab"},{"key":"2379_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s40425-018-0452-5","volume":"6","author":"ZF Wen","year":"2018","unstructured":"Wen ZF, et al. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1. J Immunother Cancer. 2018;6:151. https:\/\/doi.org\/10.1186\/s40425-018-0452-5.","journal-title":"J Immunother Cancer"},{"key":"2379_CR25","doi-asserted-by":"publisher","first-page":"110868","DOI":"10.1016\/j.intimp.2023.110868","volume":"124","author":"A Du","year":"2023","unstructured":"Du A, Yang Q, Sun X, Zhao Q. Exosomal circRNA-001264 promotes AML immunosuppression through induction of M2-like macrophages and PD-L1 overexpression. Int Immunopharmacol. 2023;124:110868. https:\/\/doi.org\/10.1016\/j.intimp.2023.110868.","journal-title":"Int Immunopharmacol"},{"key":"2379_CR26","doi-asserted-by":"publisher","first-page":"1093558","DOI":"10.3389\/fimmu.2023.1093558","volume":"14","author":"Y Cui","year":"2023","unstructured":"Cui Y, Shi J, Cui Y, Zhu Z, Zhu W. The relationship between autophagy and PD-L1 and their role in antitumor therapy. Front Immunol. 2023;14:1093558. https:\/\/doi.org\/10.3389\/fimmu.2023.1093558.","journal-title":"Front Immunol"},{"key":"2379_CR27","doi-asserted-by":"publisher","first-page":"216964","DOI":"10.1016\/j.canlet.2024.216964","volume":"593","author":"Y Yu","year":"2024","unstructured":"Yu Y, et al. Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation. Cancer Lett. 2024;593:216964. https:\/\/doi.org\/10.1016\/j.canlet.2024.216964.","journal-title":"Cancer Lett"},{"key":"2379_CR28","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cancergen.2015.11.001","volume":"208","author":"S Park","year":"2015","unstructured":"Park S, et al. Calreticulin mRNA expression and clinicopathological characteristics in acute myeloid leukemia. Cancer Genet. 2015;208:630\u20135. https:\/\/doi.org\/10.1016\/j.cancergen.2015.11.001.","journal-title":"Cancer Genet"},{"key":"2379_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12288-017-0849-1","volume":"34","author":"A Ahuja","year":"2018","unstructured":"Ahuja A, et al. Comparison of immunohistochemistry, cytochemistry, and flow cytometry in AML for myeloperoxidase detection. Indian J Hematol Blood Transfus Official J Indian Soc Hematol Blood Transfus. 2018;34:233\u20139. https:\/\/doi.org\/10.1007\/s12288-017-0849-1.","journal-title":"Indian J Hematol blood transfusion: official J Indian Soc Hematol Blood Transfus"},{"key":"2379_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.imbio.2018.09.006","volume":"224","author":"H Wu","year":"2019","unstructured":"Wu H, Shao Q. The role of inhibitor of binding or differentiation 2 in the development and differentiation of immune cells. Immunobiology. 2019;224:142\u20136. https:\/\/doi.org\/10.1016\/j.imbio.2018.09.006.","journal-title":"Immunobiology"},{"key":"2379_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8091746","author":"C Jumniensuk","year":"2022","unstructured":"Jumniensuk C, et al. Concordance of peripheral blood and bone marrow next-generation sequencing in hematologic neoplasms. Adv Hematol. 2022. https:\/\/doi.org\/10.1155\/2022\/8091746","journal-title":"Adv Hematol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02379-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02379-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02379-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:16:11Z","timestamp":1790583371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02379-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2379"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02379-3","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"23 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"All experimental protocols were approved by the Ethics Committee of The Second Hospital of Nanchang University (Nanchang, China). The study was in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}}],"article-number":"225"}}